Yinbiao Cao

机构：Chinese PLA General Hospital, Chinese General Hospital College of Nursing and Liberal Arts, People's Liberation Army No. 150 Hospital, Chinese People's Liberation Army

发表论文 19 篇 · 总被引 155 次 · h-index 7

代表论文

• Conversion therapy with an immune checkpoint inhibitor and an antiangiogenic drug for advanced hepatocellular carcinoma: A review (2022 · BioScience Trends · 被引 35)
• An update on diagnosis and treatment of hepatoblastoma (2023 · BioScience Trends · 被引 25)
• Comparison of survival benefit between salvage surgery after conversion therapy versus surgery alone for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis (2023 · HPB · 被引 21)
• Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition) (2024 · BioScience Trends · 被引 20)
• Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature (2022 · Frontiers in Immunology · 被引 16)
• Integrative multi-omics analysis reveals the role of tumor-associated endothelial cells and their signature in prognosis of intrahepatic cholangiocarcinoma (2024 · Journal of Translational Medicine · 被引 11)